Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04102150 |
|---|---|
| Brief Title: | Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma |
| First Submitted : | September 23, 2019 |
| First Submitted that Met QC Criteria : | September 23, 2019 |
| First Posted : | September 25, 2019 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | February 16, 2024 |